Introduction: Current available tools such as bone mineral density and biomarkers are insufficient to predict bone fragility in CKD patients. As chronic kidney disease (CKD) patients with fractures have impaired cortical bone, the characterization of bone is therefore crucial to identify patients at high risk.
展开▼
